Add a GLP-1 Weight Loss Program to your Clinic

The demand is already there — the question is who captures it

GLP-1 medications like semaglutide and tirzepatide have become the fastest-growing category in medical weight loss. If your clinic treats weight, metabolic health, or general wellness, your patients are asking about them — and if you can't offer a compliant program, they're buying it from a competitor or a direct-to-consumer brand instead. Every one of those patients is a recurring relationship, and a monthly refill, walking out the door.

The frustrating part is that most of those patients would rather buy from you. They already trust your clinic, they're in your building or on your schedule, and they'd prefer a provider who knows their history over a faceless online intake form. What stops clinics from capturing that demand isn't interest — it's infrastructure. Building a GLP-1 program from scratch is heavier than it looks.

You need prescribing providers licensed in each state you want to serve, a pharmacy relationship for compounded and branded fills, dosing protocols and titration schedules, intake and lab workflows, refill logistics, and the compliance scaffolding to keep it all defensible. Heally packages all of it so you can turn the program on under your own brand instead of assembling and managing four or five vendors yourself. This is the same model behind our weight-loss clinic solution and our fully branded GLP-1 weight loss brand package.

The margin math clinic owners actually care about

A GLP-1 program is one of the few additions to a clinic that is both clinically relevant to a huge share of your patients and structured as recurring monthly revenue. A patient on semaglutide or tirzepatide isn't a one-time visit — they're a monthly refill, a follow-up cadence, and an ongoing relationship that can extend into labs, other programs, and referrals. Compared with the episodic, insurance-dependent revenue most clinics live on, a cash-pay GLP-1 subscription is remarkably predictable, and predictability is what makes a practice financeable and scalable.

Because there are no startup fees and no long-term contracts, you're not underwriting a big fixed cost before you see whether the program takes. You set your patient-facing price; Heally's costs for software, provider visits, and pharmacy fulfillment come out of that margin. Partners across our network average a $127K annual revenue increase after adding programs like this — not a promise for your clinic specifically, but a signal of what a well-run recurring program can do. On a demo we'll model your actual numbers based on your pricing and expected volume, so you see the unit economics before you commit anything.

The other number that matters is the one you're losing today. Every patient who asks about GLP-1 and gets no answer is a patient who signs up with a direct-to-consumer brand instead — and once they've onboarded elsewhere, with their card on file and their refills flowing, winning them back is expensive. Offering the program isn't just new revenue; it's plugging a leak in the value you've already earned.

If GLP-1 is your first recurring program, it's often the gateway to others. Many partners add TRT or lab testing next, because the same providers, pharmacy, and platform are already in place — the second program is almost pure upside.